» Articles » PMID: 15795599

Mutation in the Sterol 27-hydroxylase Gene Associated with Fatal Cholestasis in Infancy

Overview
Publisher Wiley
Date 2005 Mar 30
PMID 15795599
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Inborn errors of bile acid synthesis are rare but potentially treatable causes of neonatal cholestasis. We here present a cholestatic infant with an ongoing cytomegalovirus infection who despite intensive treatment died of severe liver disease at 4 months of age.

Methods: The urinary steroids were investigated by electrospray mass spectrometry and gas chromatography mass spectrometry. Oxysterols in plasma were analysed by isotope dilution mass spectrometry. Mutations in the sterol 27-hydroxylase gene were detected by PCR.

Results: Glucuronidated bile alcohols, which are known to be excreted by patients with cerebrotendinous xanthomatosis (CTX) were detected in the urine. Analysis of plasma revealed markedly reduced levels of 27-hydroxycholesterol. Mutation analysis showed the presence of a stop codon in exon 7, confirming the diagnosis of CTX, a rare disease not previously diagnosed in Sweden.

Conclusions: Fetal and neonatal deaths among siblings of patients with CTX have been reported previously and the present case supports the contention that reduced activity of the sterol 27-hydroxylase may predispose to the development of neonatal cholestasis. The associated viral infection may have further precipitated the liver disease. Since CTX, like other inborn errors of bile acid synthesis may be treated with bile acids an early diagnosis is essential. Thus, the analysis of urine by electrospray mass spectrometry is highly recommended in the investigation of patients with neonatal cholestasis.

Citing Articles

Characterization of Postprandial Bile Acid Profiles and Glucose Metabolism in Cerebrotendinous Xanthomatosis.

Majait S, Meessen E, Vaz F, Kemper E, Nierop S, Olde Damink S Nutrients. 2023; 15(21).

PMID: 37960277 PMC: 10648145. DOI: 10.3390/nu15214625.


Pathophysiology and Treatment of Lipid Abnormalities in Cerebrotendinous Xanthomatosis: An Integrative Review.

Ribeiro R, Vasconcelos S, Lima P, Coelho E, Oliveira A, Gomes E Brain Sci. 2023; 13(7).

PMID: 37508912 PMC: 10377253. DOI: 10.3390/brainsci13070979.


Cerebrotendinous Xanthomatosis: Molecular Pathogenesis, Clinical Spectrum, Diagnosis, and Disease-Modifying Treatments.

Koyama S, Sekijima Y, Ogura M, Hori M, Matsuki K, Miida T J Atheroscler Thromb. 2021; 28(9):905-925.

PMID: 33967188 PMC: 8532057. DOI: 10.5551/jat.RV17055.


Sterol 27-Hydroxylase Deficiency as a Cause of Neonatal Cholestasis: Report of 2 Cases and Review of the Literature.

Lipinski P, Klaudel-Dreszler M, Ciara E, Jurkiewicz D, Ploski R, Cielecka-Kuszyk J Front Pediatr. 2021; 8:616582.

PMID: 33520900 PMC: 7838534. DOI: 10.3389/fped.2020.616582.


Chinese patient with cerebrotendinous xanthomatosis confirmed by genetic testing: A case report and literature review.

Cao L, Yang M, Liu Y, Long W, Zhao G World J Clin Cases. 2020; 8(21):5446-5456.

PMID: 33269283 PMC: 7674721. DOI: 10.12998/wjcc.v8.i21.5446.